US2007060647A1PendingUtilityA1

Gene expression regulating agent

Assignee: YUJI NAITOPriority: Feb 4, 2004Filed: Aug 4, 2006Published: Mar 15, 2007
Est. expiryFeb 4, 2024(expired)· nominal 20-yr term from priority
A61P 7/00A61P 3/04A61P 9/12A61P 9/10A61P 43/00A61P 37/08A61P 3/06A61P 27/12A61P 27/16A61P 27/06A61P 29/00A61P 25/02A61P 25/28A61P 3/10A61P 35/00A61P 27/02A23V 2002/00A61P 1/12A61P 1/04A61P 13/12A61P 11/00A61K 31/122A61K 31/21A23L 33/10A61P 21/04A61P 1/18A61P 19/06A61P 21/00A61P 13/02A61P 1/10A23L 2/52A23L 33/105
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An object of the invention is to provide a gene expression regulating agent which includes astaxanthin and/or its ester as an effective ingredient; and a food and drink having an effect of regulating gene expression which includes astaxanthin and/or its ester. Abnormal gene expression due to, for example, oxidative stress can be treated, improved, and/or prevented, and diseases caused by the abnormal gene expression can be treated, improved, and/or prevented. A gene expression regulating agent which includes astaxanthin and/or its ester as an effective ingredient; and a food and drink having an effect of regulating gene expression which includes astaxanthin and/or its ester are provided and are useful for treating, improving, and/or preventing the symptom caused by the abnormal gene expression, that is, excessive expression or suppression of expression.

Claims

exact text as granted — not AI-modified
1 . A method for regulating gene expression, comprising administering at least one of astaxanthin and an ester thereof as an effective ingredient.  
     
     
         2 . A method for regulating cytokine-related gene expression, comprising administering at least one of astaxanthin and an ester thereof as an effective ingredient.  
     
     
         3 . A method for regulating TGF-α-related gene expression, comprising administering at least one of astaxanthin and an ester thereof as an effective ingredient.  
     
     
         4 . A method for regulating collagen-related gene expression, comprising administering at least one of astaxanthin and an ester thereof as an effective ingredient.  
     
     
         5 . A method for regulating the expression of gene related to the increase and decrease of muscle cell and bone cell, comprising administering at least one of astaxanthin and an ester thereof as an effective ingredient.  
     
     
         6 . The method for regulating gene expression according to  claim 1 , wherein the at least one of astaxanthin and an ester thereof is administered as an effective ingredient in the form of a food or a drink.  
     
     
         7 . A method for using at least one of astaxanthin and an ester thereof in order to produce a gene expression regulating agent, wherein the gene expression regulating agent comprises at least one of astaxanthin and an ester thereof as an effective ingredient.

Join the waitlist — get patent alerts

Track US2007060647A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.